Breast Cancer
Conference Coverage
Whole breast radiation for breast cancer shown to be safe and effective
Whole breast radiation can cut treatment time from 6 weeks down to 3 weeks.
Conference Coverage
Personalized breast screening a step closer to reality
“Several breast cancer risk prediction models have been created, but we believe this is one of the first models designed to guide breast screening...
Conference Coverage
Novel vaccine approach halts disease after 23 years of breast cancer
“The biggest impact so far for me has been that, for the first time in more than a decade, I am not on any medication. That’s really amazing.”
Latest News
Previous breast cancer doesn’t increase poor outcomes in pregnancy, study finds
Mothers with cancer diagnoses were more likely to undergo cesarean section, however.
Feature
Despite Katie Couric’s advice, doctors say ultrasound breast exams may not be needed
Research hasn’t found that women are any less likely to die from breast cancer if they get a supplemental ultrasound or MRI after a negative...
Conference Coverage
Findings may be practice changing for early breast cancer patients
A radiation boost to the tumor bed during whole breast irradiation was as safe and effective as delivering the boost sequentially.
From the Journals
Study affirms better breast cancer outcomes when chemo comes first
Survival is better when high-risk breast cancer patients receive chemo first, followed by abemaciclib and estrogen therapy.
Latest News
Vaginal estrogen not recommended with aromatase inhibitors
“Patients who are taking aromatase inhibitors should try alternative strategies for management of genitourinary symptoms.”
Feature
Hair straighteners’ risk too small for docs to advise against their use
Primary care doctors are unlikely to address the increased risk of uterine cancer in women who frequently use hair straighteners that a new study...
Latest News
Reminder that COVID-19 and cancer can be a deadly combo
“This analysis provides additional empirical evidence on the magnitude of risk to patients with cancer whose immune systems are often weakened...
From the Journals
Cost paramount when choosing metastatic breast cancer treatment
“Our analysis provides quantifiable evidence to help providers choose lower priced, but equally effective sequences of drugs.”